CAS 2504-32-7
:Ácido 1-(4-clorobenzoil)-5-hidroxi-2-metil-1H-indol-3-acético
- 1-(4-Chlorobenzoyl)-5-Hydroxy-2-Methyl-3-Indoleacetic Acid
- 1-(4-Chlorobenzoyl)-5-hydroxy-2-methyl-1H-indole-3-acetic acid
- 1-(p-Chlorobenzoyl)-5-hydroxy-2-methylindole-3-acetic acid
- 1H-indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-hydroxy-2-methyl-
- 2-(1-(4-Chlorobenzoyl)-5-hydroxy-2-methyl-1H-indol-3-yl)acetic acid
- 5-Hydroxyindomethacin
- Demethylindomethacin
- Desmethylindomethacin
- Indole-3-acetic acid, 1-(p-chlorobenzoyl)-5-hydroxy-2-methyl-
- O-Desmethylindomethacin
5-hydroxy Indomethacin
CAS:5-hydroxy Indomethacin is a metabolite of indomethacin .1It is formed from indomethacin in rabbit hepatic microsomes.
Fórmula:C18H14ClNO4Cor e Forma:SolidPeso molecular:343.76O-Desmethyl Indomethacin
CAS:Produto ControladoApplications The major metabolite of Indomethacin.
References Lewis, R., et al.: J. Clin. Invest., 53, 1607 (1974), Alvan, G., et al.: Clin. Pharmacol. Ther., 18, 364 (1975), Mungall, D., et al.: J. Pharm. Sci., 73, 1000 (1984), Baldwin, S., et al.: Xenobiotica, 25, 261 (1995),Fórmula:C18H14ClNO4Cor e Forma:NeatPeso molecular:343.76O-Desmethyl indomethacin
CAS:O-Desmethyl indomethacin is a metabolite of indomethacin that has been shown to be a potent cytotoxic agent and may have potential as an anticancer drug. It inhibits the mitochondrial membrane potential in HL60 cells, which causes significant cytotoxicity. The target tissue for O-desmethyl indomethacin is not known, but it has been shown to be effective against cancer cells in clinical studies. O-Desmethyl indomethacin binds to glucocorticoid receptors in the cytoplasm and inhibits organic anion transporters, leading to its accumulation in urine samples. Studies have also shown that O-desmethyl indomethacin is excreted by infants through breast milk and eliminated with other metabolites through the preparative high performance liquid chromatography (HPLC).
Fórmula:C18H14ClNO4Pureza:Min. 95%Peso molecular:343.76 g/molRef: 3D-FD21281
Produto descontinuado





